Patents by Inventor Adolfo Maria TAMBELLA

Adolfo Maria TAMBELLA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11154532
    Abstract: The present disclosure describes methods and uses of biophotonic compositions which comprise at least one oxidant and at least one chromophore capable of activating the oxidant, in association with a pharmacologically acceptable carrier for the treatment of otitis externa.
    Type: Grant
    Filed: April 6, 2020
    Date of Patent: October 26, 2021
    Assignee: VETOQUINOL S.A.
    Inventors: Francesco Bellini, Matteo Cerquetella, Adolfo Maria Tambella, Andrea Spaterna, Nikolaos Loupis, David Ohayon, Remigio Piergallini
  • Publication number: 20200230101
    Abstract: The present disclosure describes methods and uses of biophotonic compositions which comprise at least one oxidant and at least one chromophore capable of activating the oxidant, in association with a pharmacologically acceptable carrier for the treatment of otitis externa.
    Type: Application
    Filed: April 6, 2020
    Publication date: July 23, 2020
    Inventors: Francesco BELLINI, Matteo CERQUETELLA, Adolfo Maria TAMBELLA, Andrea SPATERNA, Nikolaos LOUPIS, David OHAYON, Remigio PIERGALLINI
  • Patent number: 10610513
    Abstract: The present disclosure describes methods and uses of biophotonic compositions which comprise at least one oxidant and at least one chromophore capable of activating the oxidant, in association with a pharmacologically acceptable carrier for the treatment of otitis externa.
    Type: Grant
    Filed: January 11, 2017
    Date of Patent: April 7, 2020
    Assignee: KLOX TECHNOLOGIES LIMITED
    Inventors: Francesco Bellini, Matteo Cerquetella, Adolfo Maria Tambella, Andrea Spaterna, Nikolaos Loupis, David Ohayon, Remigio Piergallini
  • Publication number: 20190029994
    Abstract: The present disclosure describes methods and uses of biophotonic compositions which comprise at least one oxidant and at least one chromophore capable of activating the oxidant, in association with a pharmacologically acceptable carrier for the treatment of otitis externa.
    Type: Application
    Filed: January 11, 2017
    Publication date: January 31, 2019
    Inventors: Francesco BELLINI, Matteo CERQUETELLA, Adolfo Maria TAMBELLA, Andrea SPATERNA, Nikolaos LOUPIS, David OHAYON, Remigio PIERGALLINI